These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 69049)

  • 1. [Whole blood- and plasma viscosity in the presence of coronary risk factors. Investigations concerning the characteristics of blood flow and viscosity-effective plasma components in patients with coronary risk factors and risk factor combinations (author's transl)].
    Leonhardt H; Uthoff A; Uthoff C
    Klin Wochenschr; 1977 May; 55(10):481-7. PubMed ID: 69049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood viscosity in ischemic heart disease with different types of hyperlipoproteinemia].
    Dudaev VA; Evdokimov VV
    Kardiologiia; 1977 Jun; 17(6):79-82. PubMed ID: 197288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of blood viscosity following plasma exchange.
    Kilpatrick D; Fleming J; Clyne C; Thompson GR
    Atherosclerosis; 1979 Mar; 32(3):301-6. PubMed ID: 465118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statistical research on the lipides electrophoresis and on double pre-beta lipoprotein (author's transl)].
    La Paglia S; Liverani F
    Quad Sclavo Diagn; 1976 Jun; 12(2):173-9. PubMed ID: 193141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship of rate of red cell electrophoresis, serum conductivity and viscosity and blood lipids in coronary heart disease and hyperlipidemia (author's transl)].
    Shi YD; Liang ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Dec; 8(4):249-54. PubMed ID: 7307960
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rheologic changes in the postprandial phase].
    Leschke M; Saddig C; Kleophas W; Toeller M; Reinauer H; Strauer BE
    Klin Wochenschr; 1990; 68 Suppl 22():89-94. PubMed ID: 2087087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of particular lipid and protein component on viscosity of human plasma (author's transl)].
    Czarnecka H
    Przegl Lek; 1980; 37(12):777-81. PubMed ID: 7208965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of serum beta-lipoprotein subfraction determination (author's transl)].
    Yang CG
    Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Sep; 9(3):219-22. PubMed ID: 7338180
    [No Abstract]   [Full Text] [Related]  

  • 9. [The whole blood and plasma viscosity changes in course of acute myocardial infarction].
    Turczyński B; Słowińska L; Szczesny S; Baschton M; Bartosik-Baschton A; Szyguła J; Wodniecki J; Spyra J
    Pol Arch Med Wewn; 2002 Oct; 108(4):971-8. PubMed ID: 12642942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
    Price JF; Mowbray PI; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Eur Heart J; 1999 Mar; 20(5):344-53. PubMed ID: 10206381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
    Pfeiffer M; Tilsner V
    Med Klin; 1978 Jan; 73(2):60-2. PubMed ID: 622057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of disorders of lipid metabolism on the rheological properties of blood in patients with ischemic heart disease].
    Dudaev VA; Parfenov AS; Torkhovskaia TI; Khalilov EM; Ivanov AS
    Kardiologiia; 1983 Mar; 23(3):37-42. PubMed ID: 6855059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viscosity of blood and plasma in patients with single- and multi-vascular coronary heart disease].
    Turczyński B; Słowińska L; Szyguła J; Michalska-Małecka K; Szczurek-Katański K; Wilczewski P; Fudal M; Wodniecki J
    Pol Arch Med Wewn; 2000 Aug; 104(2):475-81. PubMed ID: 11303313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification and metabolic patterns of hyperlipoproteinemia, with special reference to serum lipoprotein metabolism].
    Kimura N; Nanbu S
    Nihon Rinsho; 1975 Nov; 33(11):3147-56. PubMed ID: 173902
    [No Abstract]   [Full Text] [Related]  

  • 16. The pre-beta lipoprotein phenomenon in relation to serum cholesterol and triglyceride levels, the Lp(a) lipoprotein and coronary heart disease.
    Dahlén G
    Acta Med Scand Suppl; 1974; 570():1-45. PubMed ID: 4377062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum lipids and precipitation test of beta-lipoproteins in patients with ischemic heart disease and healthy controls (author's transl)].
    Waich S; Quintero G; Camejo G; Acquatella H; Lalaguna F; Berrizbeitia ML
    Acta Cient Venez; 1977; 28(1):89-93. PubMed ID: 194201
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
    Frank O
    Wien Klin Wochenschr; 1974 May; 86(9):252-6. PubMed ID: 4363464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperlipidemia in patients with coronary disease (author's transl)].
    Proniewska W; Diakowski J; Kaliciński A; Modrzejewski W
    Przegl Lek; 1978; 35(4-5):456-7. PubMed ID: 211558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.